Showing results (11-20 of 121) with videos related to
Sort By:
Pageof 13
ACR Open Rheumatology|July 16, 2022
Investigation of Inactive Disease States Among Patients With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance RegistryMelissa L Mannion, Fenglong Xie, Timothy Beukelman, et al.Pediatric Rheumatology Online Journal|November 29, 2019
Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic reviewCourtney B Crayne, Chace Mitchell, Timothy BeukelmanArthritis and Rheumatism|November 1, 2008
Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: a decision analysisTimothy Beukelman, James P Guevara, Daniel A AlbertThe Journal of Rheumatology|November 18, 2011
Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic arthritis: enthesitis-related arthritis predicts persistent active diseaseKatherine J Donnithorne, Randy Q Cron, Timothy BeukelmanPediatric Rheumatology Online Journal|June 22, 2012
Back mobility and interincisor distance ranges in racially diverse North American healthy children and relationship to generalized hypermobilitySophie L Woolston, Timothy Beukelman, David D SherryPediatric Rheumatology Online Journal|June 21, 2017
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritisSonja Falvey, Lauren Shipman, Norman Ilowite, et al.Pediatric Rheumatology Online Journal|August 11, 2011
High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohortJessica L Record, Timothy Beukelman, Randy Q CronEuropean Journal of Rheumatology|March 7, 2023
Incidence of Antiphospholipid Syndrome: Is Estimation Currently Possible?Yiannis Ioannou, Timothy Beukelman, Miranda Murray, et al.Annals of the Rheumatic Diseases|January 28, 2022
Psoriasis rate is increased by the exposure to TNF inhibition in children with JIAYongdong Zhao, Erin Sullivan, Mary Beth Son, et al.The Journal of Rheumatology|April 17, 2013
Race, ethnicity, and disease outcomes in juvenile idiopathic arthritis: a cross-sectional analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) RegistrySarah Ringold, Timothy Beukelman, Peter A Nigrovic, et al.Pageof 13